Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
about
Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness AnalysisWhat is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders.Continuous drug delivery in Parkinson's disease.Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsImpact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series.Treatment of Parkinson's disease in the advanced stage.Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewApomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.Therapeutic options for continuous dopaminergic stimulation in Parkinson's diseaseWhat is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.New non-oral drug delivery systems for Parkinson's disease treatment.Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.Continuous dopaminergic delivery to minimize motor complications in Parkinson's disease.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 2003-2013: Where are we another 10 years on?Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease.Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.Intrajejunal levodopa infusion therapy for Parkinson's disease: practical and pragmatic tips for successful maintenance of therapy.Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease.Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden.Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being.Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients.Continuous Transdermal Delivery of L-DOPA Based on a Self-Assembling Nanomicellar System.Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.
P2860
Q26779605-3E4B772E-CAD6-4B7F-A5D3-5EF2C4DAC634Q30240282-5A41C818-8A9F-4928-A0E6-119B7F90E2D1Q34390800-D0074A09-9FE8-4910-A60C-2903BD8D5372Q36361513-34F466BC-0EB0-4603-BB97-80224EBA2D4EQ36651313-84BAB67B-DC2C-4820-BB24-3D5CFC69B7D0Q36725292-5E8A9DF2-0C4E-462E-9A80-9ABB4CEBBD4CQ37115650-0FE892DA-7869-48E0-A3E2-1167C1BE5752Q37302240-B7CB3D74-C693-4CEC-A298-A4A2E6865465Q37507973-5A708710-3C7E-4521-8024-3459A85A1296Q37698585-16140235-5849-43F9-85BD-36E36CCA4B5BQ37823337-50B34F49-7641-425D-9437-59B958095C75Q37824279-D1477089-4D50-4200-8DCD-A4F566384EE9Q37824441-27CF18FD-EC08-4735-9687-E4AECC72B891Q37840165-E6FD933D-8150-4B48-B501-DAEAFDED0209Q37924626-653328CA-D70F-4D8E-9B01-B66E01EBD76BQ38080952-86B3883E-9653-435B-8899-0B3D1F5D4C33Q38112219-5F2EEA71-E68D-4E34-8983-DC44C5F18221Q38215506-B4FFEEEE-1B89-439E-A283-49A619DF9456Q38331824-72AAA404-664A-479A-8582-D25F8F2C7792Q38371848-75BA4385-DE0E-4352-ABCB-1CE3755D9E36Q38476557-147B9074-E70E-41E6-9951-7BD8B8ABA459Q38823793-E6BA7E01-9B3A-4EA1-8703-232AED761A7DQ39240060-D876E496-A094-4FEE-A4E5-7A7A3C4647A9Q39578837-2B5438A8-D5E7-44A4-86BD-07CAE91121FAQ40551791-1E95D51E-F2C6-44B8-B8C3-E77A120E8DE2Q43518710-00213F35-431C-45A4-B967-525996486251Q44653366-6DD3CFBA-9D52-4481-A370-40B5C268CA70Q47652358-1742911B-1E90-4C2C-ADBE-7D290FE485D1Q48258968-C7D84F11-7810-4CE2-A1DC-64079F3F2D84Q48419574-BEACFC39-37A3-4479-8B48-E5BD45727C44Q48496658-FDF61F32-75B6-464E-917F-C9CCCBE3A81AQ48662724-0B79AC81-F45D-4C95-8FC4-7644FDFEA228Q50666990-0E5811CD-B229-40E7-B194-BD7991FB1EA6Q50730845-5B64E244-708D-4F20-B777-8CEE402E06B6Q53143036-127318DA-DAF3-4086-ADCD-B8217DE5EBCBQ53839390-02BC332C-2EF7-42A8-9982-F4690ECC373F
P2860
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@en
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@nl
type
label
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@en
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@nl
prefLabel
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@en
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@nl
P2093
P2860
P50
P921
P356
P1476
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
@en
P2093
C Pacchetti
L Manfredi
R Zangaglia
P2860
P304
P356
10.1159/000113714
P577
2008-03-06T00:00:00Z